Azora Therapeutics, Inc. (DE) AZR
NASDAQ AZR
$4.09 +0.35 (+9.36%)
At close: Nov 13, 2026 · 4:00 PM EST

Azora Therapeutics, Inc. (DE) (AZR) Return on Capital Employed [ROCE] (2018 - 2026)

Updated

Azora Therapeutics, Inc. (DE) (AZR) reported Return on Capital Employed [ROCE] of -305.71% for Q3 2026, down 150.98 percentage points from -154.73% a year earlier but up 173.44 percentage points from the prior quarter.

Analysis

Azora Therapeutics, Inc. (DE) (AZR) Return on Capital Employed [ROCE] (2018 - 2026) Analysis & Trends

For FY2025, Azora Therapeutics, Inc. (DE) posted Return on Capital Employed [ROCE] of -174.80%, up 36.84 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has a five-year change of +40.31 percentage points (FY2020 to FY2025).
  • By year, Return on Capital Employed [ROCE] came in at -211.64% in FY2024 (-61.30 pp), -150.34% in FY2023 (+75.29 pp), -225.63% in FY2022 (+287.26 pp) and -512.89% in FY2021 (-297.78 pp).
  • Five-year quarterly Return on Capital Employed [ROCE] spans a low of -479.15% in Q2 2026 and a high of -125.57% in Q1 2024.
  • Year over year, Return on Capital Employed [ROCE] gained in four of the last eight quarters, with an average year-over-year change of -58.72 percentage points.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q1 2024 (a gain of 227.64 percentage points); the low point was Q2 2026 (a drop of 267.13 percentage points).
  • Per Business Quant data, the three quarters before Q3 2026 came in at -479.15% (Q2 2026), -169.64% (Q1 2026) and -163.50% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 17.52%
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 21.60%
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 4.65%
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 9.91%
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 17.37%
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -6.15%
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 11.32%
10 Azora Therapeutics, Inc. (DE) 58.43 Mn -2.79 Mn - -305.71%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -305.71%
Jun 30, 2026 -479.15%
Mar 31, 2026 -169.64%
Dec 31, 2025 -163.50%
Sep 30, 2025 -154.73%
Jun 30, 2025 -212.02%
Mar 31, 2025 -297.86%
Dec 31, 2024 -168.99%
Sep 30, 2024 -162.50%
Jun 30, 2024 -141.39%
Mar 31, 2024 -125.57%
Dec 31, 2023 -218.74%
Sep 30, 2023 -275.55%
Jun 30, 2023 -263.38%
Mar 31, 2023 -353.21%
Dec 31, 2022 -231.58%
Sep 30, 2022 -185.35%
Jun 30, 2022 -154.56%
Mar 31, 2022 -204.81%
Dec 31, 2021 -309.20%
API Access

Azora Therapeutics, Inc. (DE) Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=AZR&period=max&api_key=YOUR_API_KEY